Ewa Starostecka

647 total citations
22 papers, 204 citations indexed

About

Ewa Starostecka is a scholar working on Physiology, Clinical Biochemistry and Surgery. According to data from OpenAlex, Ewa Starostecka has authored 22 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Clinical Biochemistry and 5 papers in Surgery. Recurrent topics in Ewa Starostecka's work include Metabolism and Genetic Disorders (8 papers), Diet and metabolism studies (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). Ewa Starostecka is often cited by papers focused on Metabolism and Genetic Disorders (8 papers), Diet and metabolism studies (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). Ewa Starostecka collaborates with scholars based in Poland, United Kingdom and United States. Ewa Starostecka's co-authors include Bożena Didycz, Maria Giżewska, Zygmunt Zdrojewicz, Maria Nowacka, Andrzej Milanowski, Agata Lange, Mirosław Bik-Multanowski, Wojciech Cichy, Bożena Mikołuć and Agnieszka Gach and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antioxidants and Redox Signaling and International Journal of Environmental Research and Public Health.

In The Last Decade

Ewa Starostecka

22 papers receiving 199 citations

Peers

Ewa Starostecka
Lisa Sniderman King United States
Cynthia A. Cameron United States
Jennifer Seminara United States
Pim de Blaauw Netherlands
Adrya Stembridge United States
G. N. Thompson Singapore
Hina Ayesha Pakistan
Lisa Sniderman King United States
Ewa Starostecka
Citations per year, relative to Ewa Starostecka Ewa Starostecka (= 1×) peers Lisa Sniderman King

Countries citing papers authored by Ewa Starostecka

Since Specialization
Citations

This map shows the geographic impact of Ewa Starostecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Starostecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Starostecka more than expected).

Fields of papers citing papers by Ewa Starostecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Starostecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Starostecka. The network helps show where Ewa Starostecka may publish in the future.

Co-authorship network of co-authors of Ewa Starostecka

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Starostecka. A scholar is included among the top collaborators of Ewa Starostecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Starostecka. Ewa Starostecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lewek, Joanna, Bożena Sosnowska, Ewa Starostecka, et al.. (2024). Clinical reality and challenges with familial hypercholesterolemia patients' management. 2024 results from the Regional Center for Rare Diseases (RCRD) Registry in Poland. International Journal of Cardiology. 419. 132667–132667. 1 indexed citations
3.
Lewek, Joanna, Maciej Banach, Paweł Matusik, et al.. (2022). Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients. Genes. 13(8). 1424–1424. 8 indexed citations
4.
5.
Lewek, Joanna, Agnieszka Konopka, Ewa Starostecka, et al.. (2021). Clinical Features of Familial Hypercholesterolemia in Children and Adults in EAS-FHSC Regional Center for Rare Diseases in Poland. Journal of Clinical Medicine. 10(19). 4302–4302. 5 indexed citations
6.
Walkowiak, Dariusz, Bożena Mikołuć, Bożena Didycz, et al.. (2021). The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland—The Results of a National Online Survey. International Journal of Environmental Research and Public Health. 18(12). 6399–6399. 7 indexed citations
7.
Bik-Multanowski, Mirosław, et al.. (2020). Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 (LAT1) gene increases the risk of obesity in infants with phenylketonuria. Molecular Genetics and Metabolism Reports. 25. 100640–100640. 6 indexed citations
8.
Podgórski, Michał, Małgorzata Stańczyk, Agnieszka Konopka, et al.. (2020). “Apple does not fall far from the tree” – subclinical atherosclerosis in children with familial hypercholesterolemia. Lipids in Health and Disease. 19(1). 169–169. 5 indexed citations
9.
Starostecka, Ewa, et al.. (2018). Difficulties in maintaining diet in patients with phenylketonuria. Pediatria i Medycyna Rodzinna. 14(1). 54–60. 1 indexed citations
10.
Mikołuć, Bożena, et al.. (2018). The quality of life of people with rare inborn errors of metabolism and their caregivers. Pediatria Polska. 93(2). 148–152. 1 indexed citations
11.
Zdrojewicz, Zygmunt, et al.. (2017). Ludzkie mleko – fakty i mity. Pediatria i Medycyna Rodzinna. 13(1). 1 indexed citations
12.
Mikołuć, Bożena, Jolanta Sawicka-Powierza, Bożena Didycz, et al.. (2017). Phenylketonuria patients’ and their parents’ knowledge and attitudes to the daily diet - multi-centre study. Nutrition & Metabolism. 14(1). 57–57. 29 indexed citations
13.
Starostecka, Ewa, et al.. (2017). Human milk – facts and myths. Pediatria i Medycyna Rodzinna. 13(1). 11–20. 2 indexed citations
14.
Bik-Multanowski, Mirosław, Ewa Jamroz, Ewa Pronicka, et al.. (2017). Long-term clinical effects of enzyme replacement therapy in MPS II. Pediatria Polska. 92(4). 373–377. 4 indexed citations
15.
Mikołuć, Bożena, Bożena Didycz, Agata Lange, et al.. (2016). Phenylketonuria patients’ and their parents’ acceptance of the disease: multi-centre study. Quality of Life Research. 25(11). 2967–2975. 8 indexed citations
16.
Bik-Multanowski, Mirosław, Ewa Jamroz, Ewa Pronicka, et al.. (2015). Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II. SHILAP Revista de lepidopterología. 6. 5–7. 2 indexed citations
17.
Bik-Multanowski, Mirosław, Mariusz Ołtarzewski, Ewa Starostecka, et al.. (2013). Molecular genetics of PKU in Poland and potential impact of mutations on BH4 responsiveness.. Acta Biochimica Polonica. 60(4). 613–6. 7 indexed citations
18.
Mikołuć, Bożena, Joanna Karpińska, Bożena Didycz, et al.. (2011). Impact of Lipophilic Antioxidants and Level of Antibodies Against Oxidized Low-Density Lipoprotein in Polish Children with Phenylketonuria. Antioxidants and Redox Signaling. 16(2). 179–182. 8 indexed citations
19.
Bik-Multanowski, Mirosław, Bożena Didycz, Maria Nowacka, et al.. (2008). Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. Journal of Inherited Metabolic Disease. 31(S2). 415–418. 79 indexed citations
20.
Bik-Multanowski, Mirosław, Maria Nowacka, Agata Lange, et al.. (2005). Use of handheld computers for assessment of prefrontal cortex function in patients with phenylketonuria. Molecular Genetics and Metabolism. 86. 142–144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026